One To Watch: Ruling On AZ’s First-In-Class Anemia Drug Roxadustat Expected Shortly

Label Warning Will Be Key

 
• By Andrew McConaghie
  
Blood transfusion
Roxadustat has been developed for patients with chronic kidney disease-induced anemia, regardless of whether they dependent on blood transfusions or not.
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip